These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20576386)

  • 1. Solid non-invasive ovarian masses on MR: histopathology and a diagnostic approach.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Saida T; Oki A; Yoshikawa H; Minami M
    Eur J Radiol; 2011 Nov; 80(2):e91-7. PubMed ID: 20576386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance evaluation of adnexal masses.
    Guerra A; Cunha TM; Félix A
    Acta Radiol; 2008 Jul; 49(6):700-9. PubMed ID: 18568564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of magnetic resonance imaging for the diagnosis of ovarian tumors: a review.
    Bazot M; Daraï E; Nassar-Slaba J; Lafont C; Thomassin-Naggara I
    J Comput Assist Tomogr; 2008; 32(5):712-23. PubMed ID: 18830100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.
    Yabuuchi H; Fukuya T; Tajima T; Hachitanda Y; Tomita K; Koga M
    Radiology; 2003 Feb; 226(2):345-54. PubMed ID: 12563124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
    Gokalp G; Topal U; Yildirim N; Tolunay S
    Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
    Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
    Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cartilaginous tumors: fast contrast-enhanced MR imaging.
    Geirnaerdt MJ; Hogendoorn PC; Bloem JL; Taminiau AH; van der Woude HJ
    Radiology; 2000 Feb; 214(2):539-46. PubMed ID: 10671608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2010; 34(2):173-6. PubMed ID: 20351498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
    Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
    J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: pathologic correlation study.
    Onishi M; Furukawa A; Takahashi M; Murata K
    Eur J Radiol; 2008 Feb; 65(2):286-92. PubMed ID: 17683886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors.
    Thomassin-Naggara I; Daraï E; Cuenod CA; Rouzier R; Callard P; Bazot M
    J Magn Reson Imaging; 2008 Jul; 28(1):111-20. PubMed ID: 18581400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of dynamic MRI studies in parotid tumors.
    Alibek S; Zenk J; Bozzato A; Lell M; Grunewald M; Anders K; Rabe C; Iro H; Bautz W; Greess H
    Acad Radiol; 2007 Jun; 14(6):701-10. PubMed ID: 17502260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an MR imaging strategy for diagnosis of ovarian masses.
    Imaoka I; Wada A; Kaji Y; Hayashi T; Hayashi M; Matsuo M; Sugimura K
    Radiographics; 2006; 26(5):1431-48. PubMed ID: 16973774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between malignant and benign ovarian tumors by magnetic resonance imaging.
    Chen M; Wang WC; Zhou C; Zhou NN; Cai K; Yang ZH; Zhao WF; Li SY; Li GZ
    Chin Med Sci J; 2006 Dec; 21(4):270-5. PubMed ID: 17249204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of ovarian hemorrhage.
    Nishino M; Hayakawa K; Iwasaku K; Togashi K; Ueda H; Sago T; Noguchi M
    Eur J Radiol; 2004 Jul; 51(1):34-40. PubMed ID: 15186882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preoperative differential diagnosis of cystic adnexal tumors: double-contrast MRT].
    Reuter M; Steffens JC; Schüppler U; Muhle C; Brinkmann G; Kohl A; Weisner D; Lüttges J; Spielmann RP; Heller M
    Rofo; 1996 May; 164(5):394-400. PubMed ID: 8634400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinosarcoma of the uterus: MR findings.
    Tanaka YO; Tsunoda H; Minami R; Yoshikawa H; Minami M
    J Magn Reson Imaging; 2008 Aug; 28(2):434-9. PubMed ID: 18666176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.